Gilead Sciences, Inc. (GILD) stock analysis
In our weekly check, Gilead Sciences, Inc. is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 15 pass, warnings: 2, red flags: 6.
About Gilead Sciences, Inc.
Gilead Sciences, Inc. is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NASDAQ as GILD.
What our checks show for GILD
Red flags
- Net debt is 15.3x a year of EBITDA (debt/equity 2.01). That limits room in a downturn and raises refinancing risk.
- The net margin fell by 35.3 points over 5 years, to -12.5%: the company keeps less of each sale as profit.
- Earnings per share fell 5.4% a year over the last 3 years.
- The company is losing money: the net margin is -12.5%.
- Gilead Sciences, Inc. pays a dividend while losing money: it is funded from reserves or debt.
- Recovering from its deepest fall took about 4.7 years.
Warning signs
- Revenue grew only 4.3% a year over the last 3 years.
- The stock has fallen as much as 54% from a peak. Would you have held through that?
Strengths
- Operating profit covers interest 11.6 times over.
- The gross margin is 79.9% and has risen by 4.1 points: pricing power is holding.
- Operating cash flow is 3.75x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 73.7% a year over the next years.
- Analysts expect the net margin to improve by 51.1 points from today's -12.5%.
- Free cash flow is 44.5% of revenue: cash for dividends, buybacks or growth.
Next earnings report: 2027-02-09
Similar companies
NVO · AMGN · PFE · AZN · NVS · BMY
Questions
What grade does Gilead Sciences, Inc. (GILD) have?
In our weekly check, Gilead Sciences, Inc. is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 15 pass, warnings: 2, red flags: 6. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of GILD stock?
This week's biggest flags for Gilead Sciences, Inc.: High debt, Margins falling, Weak EPS growth. In total 8 of 23 checks show a warning or a red flag.
What does Gilead Sciences, Inc. do?
Gilead Sciences, Inc. is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NASDAQ as GILD.
When does Gilead Sciences, Inc. report earnings next?
The next earnings report is expected on 2027-02-09. We re-run the checks every week, so the grade can change after it.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis